本页面由Tiger Trade Technology Pte. Ltd.提供服务

The Oncology Institute

3.21
+0.09002.88%
盘后3.300.0900+2.80%17:08 EDT
成交量:108.18万
成交额:353.26万
市值:3.16亿
市盈率:-5.90
高:3.34
开:3.13
低:3.12
收:3.12
52周最高:4.88
52周最低:1.14
股本:9,838.13万
流通股本:8,243.95万
量比:0.70
换手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-0.5445
每股收益(LYR):-0.5445
净资产收益率:-4132.17%
总资产收益率:-13.37%
市净率:-20.09
市盈率(LYR):-5.90

数据加载中...

2021/10/12

重要事件披露

8-K - Current report
2021/10/12

企业合并公告

425 - Prospectuses and communications, business combinations
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/29

企业合并公告

425 - Prospectuses and communications, business combinations
2021/06/29

重要事件披露

8-K - Current report
2021/06/28

重要事件披露

8-K - Current report
2021/06/28

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/24

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/05/18

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]